ArticleBMC complementary medicine and therapies2026
Antibiofilm activity against common pathogenic bacteria in Thailand and liquid chromatography-quadrupole time-of-flight mass spectrometry chemical profiling of Ha-Rak formula and its components: an in vitro study.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBacterial biofilms reduce antibiotic penetration, create tolerant bacterial subpopulations, and contribute to difficult-to-treat infections and antimicrobial resistance (AMR). The Ha-Rak Formula (HRF), a traditional Thai polyherbal remedy used for febrile illnesses, has not been systematically evaluated for antibiofilm activity.
objectiveThis study assessed the in vitro antibiofilm effects of HRF and its five constituent herbs against clinically relevant bacterial pathogens in Thailand and characterized their chemical profiles using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
methodsWater and 80% ethanol extracts were prepared from authenticated roots and commercially sourced root-stem materials. Minimum inhibitory concentrations (MICs) against six pathogenic bacteria were determined by broth microdilution at final concentrations of 64 - 16,384 µg/mL. Biofilm biomass was quantified by crystal violet staining at final extract concentrations of 400 and 1000 µg/mL, and untargeted LC-QTOF-MS with multivariate analysis was used for chemical profiling.
resultsAll extracts had MIC values > 16,384 µg/mL against planktonic cells, except the ethanol extract of root-derived HRF, which inhibited Klebsiella pneumoniae ATCC 13883 only at the highest tested concentration (MIC = 16,384 µg/mL). In contrast, root-derived extracts reduced biofilm biomass across multiple species at sub-MIC concentrations. Ethanol extracts displayed distinct chemical profiles enriched in putative carbohydrates and conjugates.
conclusionsThese findings indicate that HRF has stronger activity against biofilm formation than against planktonic bacterial growth under the conditions tested. Root-only and root-stem formulations both exhibited antibiofilm activity under the conditions tested, while water and ethanol extracts showed distinct chemical profiles. Further standardization, safety assessment, and mechanistic studies are required before clinical translation.
Indexed as
Identifiers
42482052What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.